Get the Stockscreener App
19.05
5.72%
1.03
After Hours:
19.09
0.04
+0.21%
Direxion Daily S P Biotech Bear 3 X Shares stock is traded at $19.05, with a volume of 3.29M.
It is up +5.72% in the last 24 hours and down -9.29% over the past month.
See More
Previous Close:
$18.02
Open:
$18.65
24h Volume:
3.29M
Relative Volume:
1.18
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.86%
1M Performance:
-9.29%
6M Performance:
-60.06%
1Y Performance:
-75.03%
1-Day Range:
$18.38
$19.57
1-Week Range:
$17.63
$20.00
52-Week Range:
$16.16
$160.50
Direxion Daily S P Biotech Bear 3 X Shares Stock (LABD) Company Profile
Name
Direxion Daily S P Biotech Bear 3 X Shares
Sector
Industry
Phone
-
Address
-
Compare LABD vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LABD
Direxion Daily S P Biotech Bear 3 X Shares
|
19.05 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.00 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.31 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.46 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
271.12 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
608.91 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily S P Biotech Bear 3 X Shares Stock (LABD) Latest News
RETL,SWKS Options - Finviz
Why (LABD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Direxion Daily FTSE China Bear 3X Shares (NYSEARCA:YANG) Short Interest Update - Defense World
Stock List: Research Stocks from Around the World - GuruFocus
Direxion Daily S&P Biotech Bear 3x Shares (LABD) Stock Trends and Sentiment 2026 - MarketBeat
Feeling Bearish? Try These ETFs That Take a Contrarian Approach - MarketBeat
RETL,SWKS Revenue Breakdown - Finviz
Understanding Momentum Shifts in (LABD) - Stock Traders Daily
Education Center - Direxion
Direxion Daily Real Estate Bull 3X Shares (NYSEARCA:DRN) Short Interest Up 21.8% in January - Defense World
TNA: Small-Caps Gain Momentum Over Mega-Cap Growth (NYSEARCA:TNA) - Seeking Alpha
Short Interest in Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Expands By 47.4% - MarketBeat
5 Small-cap Biotech ETFs to Watch - Investing News Network
A Leveraged Bet on the Broad Market or Big Tech: SPXL vs. QLD - The Motley Fool
Avoiding Lag: Real-Time Signals in (LABD) Movement - Stock Traders Daily
EDC: A Highly Leveraged Play On The Daily Movements Of Emerging Markets (NYSEARCA:EDC) - Seeking Alpha
These 2 ETFs Have Been Red-Hot: Can it Continue? - The Motley Fool
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Discipline and Rules-Based Execution in LABD Response - Stock Traders Daily
GUSH: Examining The Structure And Suitability Of This 2X Leveraged ETF (NYSEARCA: GUSH) - Seeking Alpha
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
NAIL: Favorable Macroeconomic Outlook For 2026-2027 (NYSEARCA:NAIL) - Seeking Alpha
SOXL: Time To Cash In (NYSEARCA:SOXL) - Seeking Alpha
Behavioral Patterns of LABD and Institutional Flows - Stock Traders Daily
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Short Interest in Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Drops By 40.8% - MarketBeat
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Hits New 52-Week HighTime to Buy? - MarketBeat
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Short Interest Down 73.4% in December - MarketBeat
Direxion Daily TSM Bull 2X Shares (NASDAQ:TSMX) Short Interest Update - MarketBeat
Earn 8% and (Potentially) 3x the S&P’s Return This Year, but There Is a Catch - 24/7 Wall St.
Bet Against Big Banks in 2026 With FAZ - 24/7 Wall St.
The 2X Long INTC (INTW) fund rose by 13.10% with a trading value of $111.98 million. - Sahm
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Shares Gap UpStill a Buy? - MarketBeat
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Direxion Daily Natural Gas Related Bear 3x Shares Direxion Shares ETF Trust - GuruFocus
(LABD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Direxion’s Aerospace & Defense ETF Is Up Almost 150% - 24/7 Wall St.
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Short Interest Up 51.8% in December - MarketBeat
Direxion Daily TSM Bull 2X Shares (NASDAQ:TSMX) Short Interest Down 38.3% in December - MarketBeat
Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.2287 - MSN
Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Declares Quarterly Dividend of $0.21 - MarketBeat
Direxion Daily MSFT Bull 2X Shares (NASDAQ:MSFU) Declares $0.27 Quarterly Dividend - MarketBeat
Direxion Daily AVGO Bull 2X Shares (NASDAQ:AVL) Announces $0.16 Quarterly Dividend - MarketBeat
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Announces Quarterly Dividend of $0.34 - MarketBeat
RDVY First Trust Rising Dividend 69.90$ +0.68%eToro - eToro
RS2K.PA Amundi Russell 2000 UCITS ETF 323.10€ +1.47%eToro - eToro
How to Trade Biotech’s Volatility with LABU/LABD | CRISPR & Cancer Stocks - ETFguide
NUGT: A Primer On The Structure And Suitability Of This 2x Leveraged ETF - Seeking Alpha
Oil Nears A Rough End To 2025, But These Energy ETFs Can Keep Traders In The Game - Benzinga
NAIL: Leveraged Exposure To The Homebuilding Industry (NYSEARCA:NAIL) - Seeking Alpha
Direxion Daily S P Biotech Bear 3 X Shares Stock (LABD) Financials Data
There is no financial data for Direxion Daily S P Biotech Bear 3 X Shares (LABD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.30%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):